CD274 and gastric cancer: Thus, our data can serve as valuable references for healthcare decision-making, such as determining whether gastric cancer indications should be included in medical insurance reimbursement and whether to consider PD-L1 expression levels, and also for manufacturers in devising future pricing strategies.